IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS

IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS was reported 26 times

IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGCETACOPLAN 2 0.0011
1 SODIUM ZIRCONIUM CYCLOSILICATE 3 0.0007
2 GEMCITABINE HYDROCHLORIDE 10 0.0002
3 HUMAN IMMUNOGLOBULIN G 2 0.0001
4 DOXAZOSIN MESYLATE 3 0.0001
5 CISPLATIN 3 0.0000
6 PAZOPANIB HYDROCHLORIDE 1 0.0000
7 BEVACIZUMAB 4 0.0000
8 CARBOPLATIN 4 0.0000
9 PACLITAXEL 3 0.0000
10 MYCOPHENOLATE MOFETIL 4 0.0000
11 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 4 0.0000
12 ALLOPURINOL 3 0.0000
13 AMLODIPINE 3 0.0000
14 NIVOLUMAB 1 0.0000
15 TACROLIMUS OINTMENT 0.1% 1 0.0000
16 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
17 FUROSEMIDE 3 0.0000
18 TACROLIMUS 1 0.0000
19 PREDNISONE 3 0.0000
20 CYCLOPHOSPHAMIDE FOR INJECTION 1 0.0000
21 CYCLOPHOSPHAMIDE 1 0.0000
22 PREDNISOLONE ORAL SOLUTION 1 0.0000
23 RITUXIMAB 1 0.0000